vimarsana.com
Home
Live Updates
Primary Analysis of the SYMPATICO trial in Mantle Cell Lymphoma : vimarsana.com
Primary Analysis of the SYMPATICO trial in Mantle Cell Lymphoma
Focusing on mantle cell lymphoma, Lori A. Leslie, MD, reviews the primary analysis of the SYMPATICO trial investigating ibrutinib-venetoclax combination therapy.
Related Keywords
Lori Leslie
,
Jamesk Mccloskey
,
Gloria Leslie
,
Hackensack University Medical Center
,
John Theurer Cancer Center
,
Research Programs
,
Peer Exchange
,
Hackensack University Medical
,
Associate Professor
,
Indolent Lymphoma
,
While Bruton
,
Lymphoma
,
Mash 2023
,
Sympatico Study
,
Sympatico Trial
,
Mantle Cell Lymphoma
,
Btk Inhibitors
,
Venetoclax
,
Ibrutinib
,
Combination Therapy
,
vimarsana.com © 2020. All Rights Reserved.